Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3793606 Title: PROCÉDÉS DE TRAITEMENT DE CANCERS ET D'AMÉLIORATION DE L'EFFICACITÉ D'AGENTS THÉRAPEUTIQUES DE REDIRECTION DE LYMPHOCYTES T

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
198039505
WO application number:
IB2019054034
Type:
European patent granted for BE
Status:
Open
Publication number:
3793606
WO publication number:
WO2019220369
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
15/05/2019
Grant date:
29/04/2026
EP publication date:
24/03/2021
WO publication date:
21/11/2019
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
29/04/2026
EP B1 publication date:
29/04/2026
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
15/05/2039

Applicant

1

Name:
Janssen Biotech, Inc.
Legal Form:
From:
29/04/2026
Address:
800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)
To:

2

Name:
Stichting Amsterdam UMC
Legal Form:
From:
29/04/2026
Address:
De Boelelaan 1117, 1081 HV Amsterdam, Netherlands (NL)
To:

Inventor

1

Name:
ADAMS, Homer
Legal Form:
Address:
Quakertown, Pennsylvania 18951, United States (US)

2

Name:
GAUDET, Francois
Legal Form:
Address:
Spring House, Pennsylvania 19477, United States (US)

3

Name:
FRERICHS, Kris
Legal Form:
Address:
1081 HV Amsterdam, Netherlands (NL)

4

Name:
VAN DE DONK, Niels
Legal Form:
Address:
1081 HV Amsterdam, Netherlands (NL)

5

Name:
VERKLEIJ, Christie C.P.M.
Legal Form:
Address:
1081 HV Amsterdam, Netherlands (NL)

Priority

1

Priority patent number:
201962842080 P
Priority date:
02/05/2019
Priority country:
United States (US)

2

Priority patent number:
201862736804 P
Priority date:
26/09/2018
Priority country:
United States (US)

3

Priority patent number:
201862672222 P
Priority date:
16/05/2018
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 39/395; A61K 45/06; C07K 16/28; C07K 16/30; A61K 31/454; A61K 31/69; A61K 39/00;

Publication

European Patent Bulletin

Issue number:
202618
Publication date:
29/04/2026
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
29/06/2026
Annual fee number:
8
Annual fee amount:
135 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type